Skip to Content

Adenovirus type 4 and type 7 vaccine Approval History

FDA Approved: Yes (First approved March 16, 2011)
Generic name: adenovirus type 4 and type 7 vaccine
Company: Barr Laboratories, Inc.
Treatment for: Infection Prophylaxis

Adenovirus type 4 and type 7 vaccine is an oral vaccine indicated for the prevention of febrile acute respiratory disease caused by adenovirus type 4 and type 7 in military populations.

Adenovirus Prophylaxis

Development History and FDA Approval Process for adenovirus type 4 and type 7 vaccine

DateArticle
Mar 16, 2011Approval FDA Approves the New Adenovirus Vaccine
Dec 11, 2008Barr's BLA for Adenovirus Type 4 and 7 Live Oral Vaccines Accepted for Filing by FDA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide